Sep 16, 2013, 14:00 PM by Michael Croft

NPR | Forensic scientists are calling for the creation of an international group to conduct DNA-identification on remains found after disasters or wars.

Sep 16, 2013, 12:00 PM by Michael Croft

Bio-IT World | The tranSMART Foundation today released tranSMART version 1.1. Originally developed as an internal project by Johnson & Johnson, this new version of the cloud-based data sharing solution eliminates the need for user organizations to purchase commercial software and integrates significant new contributions by the developer community over the past year into one new release.

Sep 13, 2013, 07:00 AM by Michael Croft

Sacramento News 10 | The University of California, Davis is putting the finishing touches on BGI Davis--home for the university's collaboration with BGI. The lab will house 20 sequencers.

Sep 12, 2013, 10:00 AM by Michael Croft

Bio-IT World Roundup | Cubist Pharmaceuticals has completed a $704 million acquisition of Trius Therapeutics.

Sep 12, 2013, 09:00 AM by Michael Croft

Bio-IT World | Evotec and the Harvard Stem Cell Institute (HSCI) launched a strategic partnership to identify compounds that prevent or slow the loss of motor neurons, which is characteristic of the human disease amyotrophic lateral sclerosis (ALS). The collaboration is called CureMN (CureMotorNeuron).

Sep 12, 2013, 06:00 AM by Michael Croft

Computerworld | Data storage is an ever present question and concern for many companies. Computerworld breaks out 14 points to consider as you build a data storage plan.

Sep 11, 2013, 12:00 PM by Michael Croft

Computerworld | Harvard and MIT have been awarded $25 million in NSF grant money to work on artificial intelligence. Researchers will study how the brain creates intelligence and how that process can be replicated in machines.

Sep 10, 2013, 16:00 PM by Michael Croft

Bio-IT World  | Bayer HealthCare and the Broad Institute have announced a strategic alliance in oncogenomics and drug discovery in order to jointly discover and develop therapeutic agents that selectively target cancer genome alterations over a period of five years.

Sep 10, 2013, 15:00 PM by Michael Croft

Chemical & Engineering News | As part of its 90th Anniversary issue, Chemical & Engineering News highlighted nine areas of chemistry that had a profound effect on the planet including antibiotics, computational chemistry, and structural biology.

Sep 10, 2013, 13:00 PM by Michael Croft

Xconomy | Amicus Therapeutics and Biogen Idec announced a deal today to discover, develop and commercialize small molecule drugs for Parkinson's Disease.

Sep 9, 2013, 14:00 PM by Michael Croft

Bloomberg Businessweek | Isis Pharmaceuticals signed a six-year agreement with Biogen Idec to develop new therapies to treat neurological disorders.

Sep 9, 2013, 13:00 PM by Michael Croft

Sep 6, 2013, 08:00 AM by Michael Croft

New Scientist | Do we have the right to ignorance? Opinions have been swirling around the disclosure aspect of genetic data, and an article in New Scientist argues that we have the right to choose ignorance.

Sep 5, 2013, 09:00 AM by Michael Croft

Bio-IT World | Natera and Illumina entered a three-year agreement yesterday dictating that Illumina will supply Natera with the HiSeq 2500 sequencing system and associated consumables for Natera’s Panorama noninvasive prenatal test (NIPT).

Sep 4, 2013, 06:00 AM by Michael Croft

Scientific American | Researchers at the University of Chicago have built the first biotech musical instrument. The instrument relies on proteins from plants that respond to sunlight.

Sep 4, 2013, 06:00 AM by Michael Croft

Bloomberg | ImClone's Sam Waksal is making biotech plans again. Hoping to cash in on biotech's current success, Waksal is planning to spin out two units of his Kadmon Corp.

Sep 3, 2013, 11:00 AM by Michael Croft

In the Pipeline | Google is always up for a long shot, and Google Ventures is backing another one. A small biotech is working on a way to orally deliver large protein drugs.

Sep 3, 2013, 07:00 AM by Michael Croft

Business Weekly | Eagle Genomics completed a funding round worth more than $926,000 (GBP 595,000). The number puts the group a bit more than halfway to its goal.

Aug 30, 2013, 09:00 AM by Michael Croft

New York Times | The Smithsonian's "Genome: Unlocking Life's Code" exhibit has been open all summer. Three months in, the New York Times looks at what has succeeded and what has fallen short in the, "smart, playful, and... enlightening" exhibit.

Aug 30, 2013, 08:00 AM by Michael Croft

Computerworld | MIT researchers have developed a 110-core chip while looking for power-efficient ways to boost performance in mobile devices.